Summary
Specifically activated cytotoxic T cells (CL's) were raised by cocultivation in vitro of normal spleen cells with syngeneic plasmacytoma cells. These CL's were fully active both in vitro in lysing 51Cr-labelled tumor cells and in in vivo Winn assays, in inhibiting the growth of tumor cells in syngeneic mice when inoculated admixed with the tumor cells, even at ratios of 2 CL's to 1 tumor cell. However the same CL populations were only marginally effective in an immunotherapy model in which CL's were injected intravenously and tumor cells subcutaneously or intramuscularly (at a ratio of up to 100 CL/1 tumor cell). It is suggested that the in vitro conditions alter cell surface properties, thereby interfering with normal cell traffic, and that if this problem can be overcome, in vitro educated CL's may constitute a potential source of activated cells for human tumor immunotherapy.
Similar content being viewed by others
References
Andrews, G. A., Congdon, C. C., Edwards, C. L., Gengozian, N., Nelson, B., Vodopick, H.: Preliminary trials of clinical immunotherapy. Cancer Res. 27, 2535 (1967)
Aust, J. C., Jagarlomoody, S. D., McKhann, C. F.: Immunisation of lymphocytes in vitro for immunotherapy of malignant disease. Surgical Forum 21, 118 (1970)
Burton, R., Thompson, J., Warner, N. L.: In vitro induction of tumor-specific immunity. I. Development of optimal conditions for induction and assay of cytotoxic lymphocytes. J. Immunol. Methods 8, 133 (1975)
Burton, R. C., Warner, N. L.: Tumor immunity to murine plasma cell tumors. III. Detection of common tumor associated antigens on BALB/c, C3H and NZB plasmacytomas by in vivo and in vitro induction of tumor immune responses. J. Natl. Cancer Inst. (in press)
Currie, G. A.: Eighty years of immunotherapy: A review of immunological methods used for the treatment of human cancer. Br. J. Cancer 26, 141 (1972)
Fisher, J. C., Hammond, W. G.: Inhibition of tumor growth by syngeneic spleen cell tranfer. Surg. Forum 17, 102 (1966)
Golub, S. H., Morton, D. L.: Sensitisation of lymphocytes in vitro against human melanoma associated antigens. Nature 251, 161 (1974)
Gorer, P. A.: Studies in antibody response of mice to tumor innoculation. Br. J. Cancer 4, 372 (1950)
Gotohda, E., Sendo, F., Hosokawa, M., Kodama, T., Kobayashi, H.: Combination of active and passive immunisation and chemotherapy to transplantation of methylcholanthrene-induced tumor in WKA rats. Cancer Res. 34, 1947 (1974)
Gutterman, J. U., Mavligit, G., Gottlieb, J. A., Burgess, M. A., McBride, C. E., Einhorn, L., Freireich, E. J., Hersh, E. M.: Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazenoimidazole carboxamide and Bacillus Calmette-Guerin. N. Eng. J. Med. 291, 592 (1974)
Harris, A. W., Bankhurst, A. D., Mason, S., Warner, N. L.: Differentiated functions expressed by cultured mouse lymphoma cells. II. θ antigen, surface immunoglobulin and a receptor for antibody on cells of a thymoma cell line. J. Immunol. 110, 431 (1973)
Howell, S. B., Dean, J. H., Esber, E. C., Law, L. W.: Cell interactions in adoptive immune rejection of a syngeneic tumor. Int. J. Cancer 14, 662 (1974)
Jeejeebhoy, H. F.: Stimulation of tumor growth by the immune response. Int. J. Cancer 13, 665 (1974)
Kall, M. A., Hellstrom, I.: Specific stimulatory and cytotoxic effects of lymphocytes sensitised in vitro to either alloantigens or tumor antigens. J. Immunol. 114, 1083 (1975)
Kedar, E., Ortiz de Landazuri, M., Fahey, J. L.: Enzymatic enhancement of cell-mediated cytotoxicity and antibody-dependent cell cytotoxicity. J. Immunol. 11, 26 (1974)
Kuperman, O., Fortner, G. W., Lucas, Z. J.: Immune response to a syngeneic mammary adenocarcinoma. II. In vitro generation of cytotoxic lymphocytes. J. Immunol. 115, 1277 (1975)
Laskov, R., Scharff, M. D.: Synthesis assembly and secretion of gamma globulin by mouse myeloma cells. I. Adaption of the Merwin plasma cell tumor-II to culture, cloning, and characterisation of gamma globulin subunits. J. Exp. Med. 131, 515 (1970)
Lundak, R. L., Raidt, D. J.: Cellular immune response against tumor cells. I. In vitro immunisation of allogeneic and syngeneic mouse spleen cell suspensions against DBA mastocytoma cells. Cell. Immunol. 9, 60 (1973)
McKhann, C. F., Jagarlamoody, S. M.: Evidence for immune reactivity against neoplasms. Transplant. Rev. 7, 55 (1971a)
McKhann, C. F., Jagarlamoody, S. M.: In vitro immunisation for immunotherapy: Morphological and fundamental aspects of immunity. New York: Plenum 1971b
Manson, L. A., Plamer, J. C.: Induction of the immune response to cell surface antigens in vitro. In vitro 2, 186 (1975)
Mathé, G., Amiel, J. L., Schwarzenburg, L., Schneider, M., Cattan, A., Schlumberger, J. R., Hayat, A., DeVassal, F.: Active immunotherapy for acute lymphoblastic leukaemia. Lancet 1969 I, 697
Nadler, S. H., Moore, G. E.: Immunotherapy of malignant disease. Arch. Surg. 99, 376 (1969)
Nomoto, K., Mashiba, H., Sato, M., Takeya, K.: In vitro detection of tumor specific antigens. Gann Monograph on Cancer Research 16, 211 (1974)
Prehn, R. T.: Perspectives on oncogenesis: does immunity stimulate or inhibit neoplasia? J. Reticuloendothel. Soc. 10, 1 (1971)
Prehn, R. T., Lappe, M. A.: An immunostimulatory theory of tumor development. Transplant. Rev. 7, 26 (1971)
Rollinghoff, M., Wagner, H.: In vitro induction of tumor specific immunity: requirements for T lymphocytes and tumor growth inhibition in vivo. Eur. J. Immunol. 3, 471 (1973a)
Rollinghoff, M., Wagner, H.: In vivo protection against murine plasma cell tumor growth by in vitro activated syngeneic lymphocytes. J. Natl. Cancer Inst. 51, 1317 (1973b)
Rollinghoff, M., Warner, N. L.: Specificity of in vivo tumor rejection assessed by mixing immune spleen cells with target and unrelated tumor cells. Proc. Soc. Exp. Biol. Med. 144, 813 (1973)
Rollinghoff, M., Rouse, B. T., Warner, N. L.: Tumor immunity to murine plasma cell tumors. I. Tumor associated transplantation antigens of NZB and BALB/c plasma cell tumors. J. Natl. Cancer Inst. 50, 159 (1973)
Rouse, B. T., Wagner, H., Harris, A. W.: In vivo activity of in vitro immunised lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes. J. Immunol. 108, 1353 (1972)
Rouse, B. T., Wagner, H.: The in vivo activity of in vitro immunised mouse thymocytes III. Fate of in vitro immunised thymocytes. Transplantation 16, 161 (1973)
Rouse, B. T., Rollinghoff, M., Warner, N. L.: Tumor immunity to murine plasma cell tumors. II. Essential role of T lymphocytes in immune response. Eur. J. Immunol. 3, 218 (1973)
Seigler, H. F., Shingleton, W. W., Metzgar, R. S., Buckley C. E., Bergoc, P. M., Miller, D. S., Fetter, B. F., Phaup, M. B.: Nonspecific and specific immunotherapy in patients with melanoma. Surgery 72, 162 (1972)
Sharma, B., Terasaki, P. I.: In vitro immunisation to cultured human tumor cells. Cancer Res. 34, 115 (1974)
Shellam, G. R.: Studies on a gross-virus induced lymphoma in the rat. I. The cell-mediated immune response. Int. J. Cancer 14, 65 (1974)
Small, M., Trainin, N.: Inhibition of syngeneic fibrosarcoma growth by lymphocytes sensitised on tumor-cell monolayers in the presence of the thymic humoral factor. Int. J. Cancer 15, 962 (1975)
Spitler, L. E., Levin, A. S., Wybran, J.: Combined immunotherapy in malignant melanoma. Regression of metastatic lesions in two patients concordant in timing with systemic administration of transfer factor and Bacillus Calmette Guerin. Cell. Immunol. 21, 1 (1976)
Treves, A. J., Carnaud, C., Trainin, N., Feldman, M., Cohen, I. R.: Enhancing T lymphocytes from tumor-bearing mice suppress host resistance to a syngeneic tumor. Eur. J. Immunol. 4, 722 (1974)
Treves, A. J., Cohen, I. R., Feldman, M.: Immunotherapy of lethal metastases by lymphocytes sensitised against tumor cells in vitro. J. Natl. Cancer Inst. 54, 777 (1975)
Umiel, T., Tainin, N.: Immunological enhancement of tumor growth by syngeneic thymus derived lymphocytes. Transplantation 18, 244 (1974)
Van Loveren, H., DenOtter, W.: In vitro activation of armed macrophages and the therapeutic application in mice. J. Natl. Cancer Inst. 51, 1917 (1974)
Wagner, H., Rollinghoff, M.: In vitro induction of tumor specific immunity. I. Parameters of activation and cytotoxic reactivity of mouse lymphoid cells immunised in vitro against syngeneic and allogeneic plasma cell tumors. J. Exp. Med. 138, 1 (1973)
Warnatz, H., Scheiffarth, F.: Cell-mediated immune response of in vitro sensitised lymphocytes to isogeneic methylcholanthrene-induced tumor cell lines. Transplantation 18, 273 (1974)
Warner, N. L., Rouse, B. T.: Immunological responses of mice to induced plasma cell tumors. In the Nature of Leukaemia (Vincent, P., ed.), pp. 67–109. Proceedings of the International Cancer Congress, U.I.C.C. 1972
Winn, H. J.: Immune mechanisms in homotransplantation. I. The role of serum antibody and complement in the neutralisation of lymphoma cells. J. Immunol. 84, 530 (1959)
Author information
Authors and Affiliations
Additional information
National Health and Medical Research Council postgraduate research scholar
Rights and permissions
About this article
Cite this article
Burton, R.C., Warner, N.L. In vitro induction of tumor-specific immunity. IV. Specific adoptive immunotherapy with cytotoxic T cells induced in vitro to plasmacytoma antigens. Cancer Immunol Immunother 2, 91–99 (1977). https://doi.org/10.1007/BF00200054
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00200054